​

Cencora (COR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

COR Stock Forecast

Cencora (COR) stock forecast, based on 46 Wall Street analysts, predicts a 12-month average price target of $358.14, with a high of $430.00 and a low of $330.00. This represents a 10.77% increase from the last price of $323.32.

$200 $250 $300 $350 $400 $450 High: $430 Avg: $358.14 Low: $330 Last Closed Price: $323.32

COR Stock Rating

Cencora stock's rating consensus is Buy, based on 46 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 33 Buy (71.74%), 12 Hold (26.09%), 1 Sell (2.17%), and 0 Strong Sell (0.00%).

Buy
Total 46 1 12 33 Strong Sell Sell Hold Buy Strong Buy

COR Price Target Upside V Benchmarks

TypeNameUpside
StockCencora10.77%
SectorHealthcare Stocks 15.45%
IndustryMedical Distribution Stocks10.82%

Price Target Trends

1M3M12M
# Anlaysts1525
Avg Price Target$330.00$365.20$381.24
Last Closing Price$323.32$323.32$323.32
Upside/Downside2.07%12.95%17.91%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 26483--15
Aug, 26482--14
Jul, 26482--14
Jun, 26482--14
May, 26383--14
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 19, 2026Ryan HalstedRBC Capital$330.00$316.134.39%2.07%
Aug 07, 2026Morgan Stanley$346.00$323.297.02%7.01%
Aug 06, 2026Robert W. Baird$370.00$313.3718.07%14.44%
Aug 06, 2026Kevin CaliendoUBS$430.00$313.5137.16%33.00%
Aug 06, 2026Evercore ISI$350.00$317.2210.33%8.25%
Jun 10, 2026Barclays$350.00$279.5725.19%8.25%
May 11, 2026Stephen BaxterWells Fargo$331.00$261.0826.78%2.38%
May 08, 2026Morgan Stanley$342.00$265.5828.77%5.78%
May 07, 2026UBS$412.00$256.0160.93%27.43%
Apr 08, 2026Evercore ISI$360.00$324.9310.79%11.34%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 08, 2026RBC CapitalSector PerformSector Performhold
Aug 19, 2026RBC CapitalSector Performinitialise
Aug 07, 2026Morgan StanleyOverweightOverweighthold
Aug 06, 2026UBSBuyBuyhold
Aug 06, 2026Evercore ISIOutperformOutperformhold
Aug 06, 2026CitigroupBuyBuyhold
May 11, 2026Wells FargoOverweightOverweighthold
May 07, 2026UBSBuyBuyhold
Apr 28, 2026William BlairMarket Performinitialise
Mar 17, 2026Leerink PartnersOutperformOutperformhold

Financial Forecast

EPS Forecast

$0 $5 $10 $15 $20 $25 Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported$7.48$8.15$8.62$7.60$8.03----
Avg Forecast$9.23$2.78$11.93$13.65$15.16$16.59$18.15$20.68$22.96
High Forecast$9.47$3.33$11.95$13.67$15.46$17.17$20.01$21.30$23.65
Low Forecast$8.79$2.23$11.90$13.60$14.89$16.13$16.40$20.26$22.49
Surprise %-18.96%193.17%-27.75%-44.32%-47.03%----

Revenue Forecast

$0 $100B $200B $300B $400B $500B Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported$213.99B$238.59B$262.17B$293.96B$321.33B----
Avg Forecast$212.20B$708.52M$259.67B$292.54B$320.22B$340.96B$363.69B$404.37B$443.83B
High Forecast$216.34B$850.22M$261.65B$293.25B$324.52B$348.77B$364.51B$413.74B$454.12B
Low Forecast$204.32B$566.81M$257.87B$291.78B$316.92B$334.75B$362.87B$398.07B$436.91B
Surprise %0.84%33574.22%0.96%0.49%0.35%----

Net Income Forecast

$0 $1B $2B $3B $4B $5B Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported$1.54B$1.70B$1.75B$1.51B$1.55B----
Avg Forecast$82.85M$91.14M$1.87B$2.73B$3.04B$3.33B$3.65B$4.14B$4.60B
High Forecast$99.43M$109.37M$2.24B$2.74B$3.10B$3.44B$4.01B$4.27B$4.74B
Low Forecast$66.28M$72.91M$1.49B$2.72B$2.98B$3.23B$3.28B$4.06B$4.51B
Surprise %1758.59%1763.96%-6.52%-44.74%-48.86%----

COR Forecast FAQ

Is Cencora stock a buy?

Cencora stock has a consensus rating of Buy, based on 46 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 33 Buy, 12 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Cencora is a favorable investment for most analysts.

What is Cencora's price target?

Cencora's price target, set by 46 Wall Street analysts, averages $358.14 over the next 12 months. The price target range spans from $330 at the low end to $430 at the high end, suggesting a potential 10.77% change from the previous closing price of $323.32.

How does Cencora stock forecast compare to its benchmarks?

Cencora's stock forecast shows a 10.77% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical distribution stocks industry (10.82%).

What is the breakdown of analyst ratings for Cencora over the past three months?

  • September 2026: 26.67% Strong Buy, 53.33% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 28.57% Strong Buy, 57.14% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 28.57% Strong Buy, 57.14% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.

What is Cencora’s EPS forecast?

Cencora's average annual EPS forecast for its fiscal year ending in September 2026 is $16.59, marking a 106.60% increase from the reported $8.03 in 2025. Estimates for the following years are $18.15 in 2027, $20.68 in 2028, and $22.96 in 2029.

What is Cencora’s revenue forecast?

Cencora's average annual revenue forecast for its fiscal year ending in September 2026 is $340.96B, reflecting a 6.11% increase from the reported $321.33B in 2025. The forecast for 2027 is $363.69B, followed by $404.37B for 2028, and $443.83B for 2029.

What is Cencora’s net income forecast?

Cencora's net income forecast for the fiscal year ending in September 2026 stands at $3.33B, representing an 114.57% increase from the reported $1.55B in 2025. Projections indicate $3.65B in 2027, $4.14B in 2028, and $4.6B in 2029.